Skip to main content

As with many other substances, a patient’s use of marijuana, both medically and recreationally, can impact physical therapy outcomes.

We have a lot yet to learn, and many issues are in flux: State laws and regulations around medical and recreational use are changing, making it imperative to understand what is and isn't permitted in your state. Similarly, FDA Controlled Substance Act classifications around the variety of products derived from cannabis and cannabinoids can be complex, with drug classifications ranging from Schedule I to Schedule V. To date, there is not enough data to make recommendations for the clinical use of topical cannabinoids.

Though our understanding is evolving, information is increasingly available as use becomes more and more common. Here are some resources that can help you gain perspective on the issue.

Log in or create a free account to keep reading.

Join APTA to get unlimited access to content.

You Might Also Like...


Study: Pre- and Post-TKR Physical Therapy Lowers Odds of Long-Term Opioid Use

Nov 5, 2021

A large-scale study found that the lowered odds are especially significant for "opioid-experienced" patients.


Five Ways Physical Therapists Can Make an Impact on the Opioid Crisis

Oct 14, 2021

Five ways that PTs can help patients and clients who are taking opioids, or who are at risk for or already have OUD.


Study: Home Health Physical Therapy Decreases Opioid Use After THA, TKA

Mar 31, 2021

Researchers found that both physical and occupational therapy led to quicker discontinuation of opioids.